Arkolith/Insider Trading/PALI/Form 4

Finley John David

CEO, CFO, DirectorPALISADE BIO, INC. (PALI) · full profile →Form 4 · filed Feb 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 12, 2026Sell(S)4K$1.75$7K27K
Feb 11, 2026Option exercise(M)13K——31K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2026Option exercise(M)13K—$027K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-006831) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML